{
  "actions": [
    {
      "acted_at": "2006-06-27", 
      "references": [
        {
          "reference": "CR S6577-6578", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2006-06-27", 
      "committee": "Committee on Commerce, Science, and Transportation", 
      "references": [
        {
          "reference": "CR S6578", 
          "type": "text of measure as introduced in Senate"
        }
      ], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Commerce, Science, and Transportation.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s3582-109", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Commerce, Science, and Transportation", 
      "committee_id": "SSCM"
    }
  ], 
  "congress": "109", 
  "cosponsors": [
    {
      "district": null, 
      "name": "Feingold, Russell D.", 
      "sponsored_at": "2006-12-08", 
      "state": "WI", 
      "thomas_id": "01331", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Grassley, Chuck", 
      "sponsored_at": "2006-06-27", 
      "state": "IA", 
      "thomas_id": "00457", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Johnson, Tim", 
      "sponsored_at": "2006-07-13", 
      "state": "SD", 
      "thomas_id": "00604", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Leahy, Patrick J.", 
      "sponsored_at": "2006-06-27", 
      "state": "VT", 
      "thomas_id": "01383", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Schumer, Charles E.", 
      "sponsored_at": "2006-06-27", 
      "state": "NY", 
      "thomas_id": "01036", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2006-06-27", 
  "number": "3582", 
  "official_title": "A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Preserve Access to Affordable Generics Act", 
  "sponsor": {
    "district": null, 
    "name": "Kohl, Herb", 
    "state": "WI", 
    "thomas_id": "01380", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2006-06-27", 
  "subjects": [
    "Commerce", 
    "Drug industry", 
    "Generic drugs", 
    "Health", 
    "Intellectual property", 
    "Marketing", 
    "Patent infringement", 
    "Pharmaceutical research", 
    "Science, technology, communications"
  ], 
  "subjects_top_term": "Commerce", 
  "summary": {
    "as": "Introduced", 
    "date": "2006-06-27", 
    "text": "Preserve Access to Affordable Generics Act - Amends the Federal Trade Commission Act to deem it to be an unfair method of competition affecting commerce for a person, in connection with the sale of a drug product, to be a party to any agreement resolving or settling a patent infringement claim in which: (1) an abbreviated new drug (generic) application filer receives anything of value; and (2) such filer agrees not to research, develop, manufacture, market, or sell the generic product for any period. Excludes a resolution or settlement that includes no more than the right to market the generic product prior to the expiration of the patent."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Preserve Access to Affordable Generics Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-07-19T20:44:39-04:00"
}